Loading...
NPI 1962634329 · Albuquerque, NM · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Recovery Services Of New Mexico, LLC is a methadone clinic provider located in Albuquerque, New Mexico. This profile covers 2 Medicare and 9 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Recovery Services Of New Mexico, LLC |
| Address | 1528 Five Points Rd Sw |
| City | Albuquerque |
| State | NM |
| ZIP | 87105 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | August 19, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $33.8M |
| Medicare | $292.1K |
The provider’s payer mix is heavily skewed toward Medicaid: lifetime Medicaid revenue is $33.8M versus total Medicare revenue of $292.1K, indicating Medicaid accounts for the overwhelming share of billed services and revenue for this clinic. This scale difference positions the organization as effectively a Medicaid-focused methadone clinic rather than a Medicare-driven operation.
Medicare revenue is extremely concentrated: the precomputed top 3 Medicare codes account for 100.0% of Medicare revenue, with G2067 alone representing $290.6K (99.4% of this provider's total Medicare revenue). This indicates the clinic’s Medicare footprint is almost entirely the OTP weekly bundle represented by G2067, while ancillary Medicare billing (e.g., G2078 at $1.6K) is immaterial.
Medicaid revenue is also highly concentrated in a small set of codes: the precomputed top 3 Medicaid codes account for 96.1% of Medicaid revenue, led by H0020 at $29.1M (86.0% of this provider's total Medicaid revenue), followed by H0025 at $2.5M (7.3%) and 80307 at $950K (2.8%). This mix shows that methadone administration (H0020) is the dominant Medicaid service line, with prevention/education (H0025) and presumptive drug testing (80307) forming the next-largest revenue streams.
The code mix and descriptions are consistent with a dedicated opioid treatment/methadone clinic: core billing centers on medication-assisted treatment and methadone administration (G2067, H0020), supplemented by behavioral services (H0025), both presumptive and definitive drug testing (80307, G0480, G0483), and routine specimen collection (36415). Together these codes imply an operational model that integrates dispensing/administration, counseling, and onsite toxicology services rather than a general medical practice.
Competitive standing is mixed across payers and codes: for Medicare, G2067 ranks #179 of 830 (79th percentile) and is described as a typical, unremarkable volume nationally, so the provider is not a national outlier even though G2067 drives nearly all Medicare revenue. In Medicaid, H0020 ranks #7 of 16 (60th percentile) which is typical for in-state peers, but H0025 ranks #1 of 15 (100th percentile) and is labeled notably above typical state volume, indicating this clinic is a state-level leader for behavioral health prevention education services.
The clinic demonstrates substantial onsite or billed laboratory activity supporting its treatment model: Medicaid lists 15.3K claims for 80307 ($950K) and 8K claims for G0480 ($837.4K), plus 1.1K claims for G0483 ($204K); 36415 appears with 18.3K claims ($146.4K) for blood draws and ranks in the 90th percentile in-state. These volumes show toxicology and specimen collection are significant operational components and secondary revenue drivers behind medication administration.
The provider has an established tenure in the Medicare NPI registry, enumerated on 2009-08-19 (~17 years ago), which supports interpreting its billing patterns as the output of a long-running clinic rather than a new entrant or short-term operation. This longevity, together with concentrated Medicaid volumes, suggests stable, sustained service delivery focused on methadone-based treatment.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,260 | $230 | $290.6K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 40 | $40 | $1.6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 2 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
9 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 559,770 | $50 | $29.1M |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | 32,180 | $80 | $2.5M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 15,320 | $60 | $950K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 7,980 | $110 | $837.4K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,120 | $180 | $204K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 18,300 | $10 | $146.4K |
| H0001 | Alcohol and/or drug assessment | 1,080 | $60 | $64.8K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,250 | $40 | $53.7K |
| 90832 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 310 | $50 | $15.3K |
How this provider's Medicaid billing volume and revenue compare to other New Mexico providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Mexico median
9 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 7 | 20 | 290,440 | $20 | $12.3M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2 | 10 | 690 | $190 | $2M |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | 1 | 20 | 7,950 | $80 | $839K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 14 | 80 | 3,340 | $60 | $595K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 8 | 50 | 530 | $90 | $323.8K |
| 90832 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 161 | 290 | 470 | $70 | $161.5K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 26 | 250 | 890 | $1 | $38K |
| H0001 | Alcohol and/or drug assessment | 3 | 10 | 110 | $50 | $26K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1 | 10 | 140 | $40 | $14.9K |
Other providers in the same ZIP code as Recovery Services Of New Mexico, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.